Skip to main content

Pseudomonas Aeruginosa Infection

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Valneva
ValnevaAustria - Vienna
1 program
1
IC43Phase 2/31 trial
Active Trials
NCT01563263Completed803Est. Dec 2015
Armata Pharmaceuticals
Armata PharmaceuticalsLOS ANGELES, CA
1 program
AB-PA01N/A1 trial
Active Trials
NCT03395743No Longer Available
Insmed
InsmedBRIDGEWATER, NJ
1 program
Liposomal amikacin for inhalationPHASE_31 trial
Active Trials
NCT01315678Completed302Est. Sep 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
InsmedLiposomal amikacin for inhalation
ValnevaIC43

Clinical Trials (3)

Total enrollment: 1,105 patients across 3 trials

NCT01315678InsmedLiposomal amikacin for inhalation

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Start: Feb 2012Est. completion: Sep 2013302 patients
Phase 3Completed
NCT01563263ValnevaIC43

Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

Start: Mar 2012Est. completion: Dec 2015803 patients
Phase 2/3Completed
NCT03395743Armata PharmaceuticalsAB-PA01

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

N/ANo Longer Available

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.